Comparison

Roflumilast European Partner

Item no. TMO-T1024-1ml
Manufacturer TargetMol
CASRN 162401-32-3
Amount 1 mL
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Smiles O(CC1CC1)C2=C(OC(F)F)C=CC(C(NC=3C(Cl)=CN=CC3Cl)=O)=C2
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias B9302-107,BYK 20869,APTA 2217,BY 217
Similar products 162401-32-3
Shipping Condition Cool pack
Available
Manufacturer - Targets
RSV|||PDE
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
403.21
Description
Roflumilast (APTA 2217) is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3', 5'-adenosine monophosphate (cAMP) and cAMP-mediated signaling.
Pathways
Metabolism|||Microbiology/Virology

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close